Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder that occurs in elderly patients. One of the main diagnostic criteria is the accumulation of heterogeneous monocytes in the peripheral blood.We further explored this cellular heterogeneity and observed that part of the leukemic clone in the peripheral blood was made of immature dysplastic granulocytes with a CD14^-/CD24⁺ phenotype. The proteome profile of these cells is dramatically distinct from that of CD14⁺/CD24^- monocytes from CMML patients or healthy donors. More specifically, CD14 ^-/CD24⁺ CMML cells synthesize and secrete large amounts of alphadefensin 1-3 (HNP1-3). Recombinant HNPs inhibit macrophage colony-stimulating factor (M-CSF)-driven differentiation of human peripheral blood monocytes into macrophages. Using transwell, antibody-mediated depletion, suramin inhibition of purinergic receptors, and competitive experimentswith uridine diphosphate (UDP)/ uridine triphosphate (UTP), we demonstrate that HNP1-3 secreted by CD14^-/ CD24⁺ cells inhibit M-CSF-induced differentiation of CD14⁺/CD24^- cells at least in part through P2Y6, a receptor involved in macrophage differentiation. Altogether, these observations suggest that a population of immature dysplastic granulocytes contributes to the CMML phenotype through production of alpha-defensins HNP1-3 that suppress the differentiation capabilities of monocytes.